In summary, our findings clarify the potential effects of SE machinery on m6A readers, and reveal the underlying functions and mechanisms of IGF2BP2/IGF2BP3‐DDX21 axis in AML, which pave the way to develop more effective therapeutic strategies for AML. This evidence concerns the gene DDX21 and acute myeloid leukemia.